Releasing IoM Drug Safety Report Could Be Early On Von Eschenbach’s Watch

One of Andrew von Eschenbach's first major steps as FDA commissioner will likely be a release of the agency task force response to the Institute of Medicine's (IoM) recommendations to improve drug safety oversight